Bolmantalate
| |
Clinical data | |
---|---|
Synonyms | LY-38851; Lilly 38851; Nandrolone adamantoate; Nandrolone adamantane-1-carboxylate; 19-Nortestosterone 17β-adamantoate |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C29H40O3 |
Molar mass | 436.633 g/mol |
3D model (JSmol) | |
| |
|
Bolmantalate (developmental code name LY-38851 or Lilly 38851), also known as 19-nortestosterone 17β-adamantoate (or nandrolone adamantoate), is an androgen and anabolic steroid and a nandrolone ester which was synthesized and developed by Eli Lilly in 1965 but was never marketed.[1][2]
See also
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 168–. ISBN 978-1-4757-2085-3.
- ↑ Rapala RT, Kraay RJ, Gerzon K (September 1965). "The adamantyl group in medicinal agents. II. Anabolic steroid 17-beta-adamantoates". J. Med. Chem. 8 (5): 580–3. doi:10.1021/jm00329a007. PMID 5867938.
PR |
| ||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
| ||||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.